Skip to main content

Patient exemption fraud

Fraud within the main NHS services that require payment upfront in return for access. It also encompasses the onward sale or supply of prescribed medication.

The financial vulnerability estimate has increased compared to last financial year primarily as a result of an increase in patients claiming a prescription exemption via Universal Credit. Also, because of optical charge evasion due to an increased expenditure. However, dental charge evasion decreased.

£268.76m
vulnerable from an expenditure of £12.2bn

Emerging trends and prevalent threats

It is a realistic possibility that some patients are onwardly trading prescription medication for personal gain. Controlled prescription medication has a lucrative street market alongside illegal drugs in the UK and abroad. The NHSCFA has noted an increase in the onward trade of prescription weight-loss medications like GLP-1 receptor agonist medications (e.g. Mounjaro and Wegovy) alongside usual prevalent types of onwardly traded medications like benzodiazepines (e.g. Valium, Xanax), opioid painkillers (e.g. oxycodone, morphine) and gabapentinoids (e.g. pregabalin).

Identity theft in order to access paid NHS services or controlled prescription medication remains highly likely. Often associated with those unlawfully in the UK due to the common misconception that they are not entitled to NHS treatment, or that NHS staff will inform Immigration Enforcement about their situation. It is also frequently associated with individuals wishing to obtain controlled medications they would not normally be prescribed.

Most commonly reported controlled drug within the onward trade of prescription medication sub-type

Most commonly stated controlled drug within onward trade of prescription medication sub-type Ranked infographic. Medical cannabis and Steroids share rank 7. Tier widths indicate rank only, not volume. 1 Opioids (not including Methadone) 2 Weight loss medication (GLP-1 Agonists) 3 Gabapentinoids 4 Benzodiazepines 5 Methadone 6 PDE5 Inhibitors (for example Viagra) 7 Medical cannabis Steroids (Corticosteroids) 8 Antibiotics 9 Antihistamine 10 Antidepressants

An emerging threat is the likelihood of NHS patients feigning injury or illness to support fraudulent claims for state benefits, in cases relating to claims of incapability to work, medical evidence may be required. This is developing alongside an increase in the number of individuals in the UK claiming Universal Credit , which reached 8.4 million in January 2026. There is also a high probability that those wishing to obtain controlled medications as a result of dependency or with the intent to onwardly trade are likely to feign injury.

Evading NHS charges for services which require payment; primarily prescription, dental and optical charges remain highly likely and prevalent. This is becoming increasingly common as a result of continual increases in these charges alongside inflation, the NHS offers a Low Income Scheme (LIS) which allows patients on low income to apply for exemption certificates from these charges. Although Real-Time Exemption Checking (RTEC) is positively impacting this area.

Case study

A media outlet has reported a patient abusing an NHS-funded patient taxi service by repeatedly using the service for non-hospital related travel. The patient was given a one-time use code by the hospital to give to a local taxi service which entitled them to one trip home after an appointment as they were unable to afford the journey themselves. They then repeatedly used the code over the next few days before it was identified by the hospital, resulting in financial loss to the trust. The patient was ordered at Magistrates to repay the taxi costs plus compensation.

PESTLE analysis

Political: Prescription charges in England remain at £9.90 per item; however, around 89% of prescription items are free due to exemptions and with other UK nations having already abolished charges, there is debate around following suit.

Economic: Rising cost of living pressures may increase false exemption claims or misuse of access to medicines for personal gain, including onward trade.

Social: Rising Universal Credit numbers may drive more exemption claims, though some incorrect claims may be due to confusion rather than intentional deception.

Technological: The use of Real Time Exemption Checking (RTEC) is so far understood to have had a positive impact in the reduction of falsely claimed exemptions, allowing eligibility to be confirmed at the point of dispensing.

Environmental: Increased pharmaceutical waste through patients requesting unnecessary medication or stockpiling can have an environmental impact, as well as the impact of NHS supply chains contributing to emissions.

Legal: Current penalties are civil rather than criminal, raising questions about deterrence for those who repeatedly claim exemptions falsely, but media coverage has also highlighted unfair or erroneous penalties.

Organisational: There is an overreliance in this area on self-declaration, although the introduction of RTEC helps combat this in prescriptions.

Media Factors: National media outlets have reported on incorrect penalty fines and patients penalised in error which can create distrust.

Reporting

During this reporting period, the NHSCFA received 1820 reports compared to last year’s total of 1308.

Patient Exemption reports by financial year, 2020 to 2021 to 2025 to 2026
Thematic area 2020-21 2021-22 2022-23 2023-24 2024-25 2025-26
Patient exemption 911 1,055 867 1,418 1,308 1,820

Help us improve cfa.nhs.uk

Tell us what's happened so we can fix the problem. Please do not provide any personal, identifiable or sensitive information.

Close

Thanks for the feedback!

Close